Literature DB >> 21031346

Non-invasive prediction of intra-amniotic inflammation in women with preterm labor.

H J Jung1, K H Park, S N Kim, J-S Hong, K J Oh, G Kim, J Y Kwon.   

Abstract

OBJECTIVE: To develop a model based on non-invasive variables to predict the probability of intra-amniotic inflammation in women with preterm labor and intact membranes.
METHODS: Transvaginal ultrasonography and digital examination for the assessment of cervical length and cervical dilatation were performed, and maternal blood was collected for the determination of C-reactive protein and white blood cell (WBC) count immediately after amniocentesis in 153 consecutive women with preterm labor. Amniotic fluid obtained by amniocentesis was cultured for aerobic and anaerobic bacteria and mycoplasmas, and the WBC was determined. Intra-amniotic inflammation was defined as an elevated amniotic fluid interleukin-6 concentration (> 2.6 ng/mL). Receiver-operating characteristics (ROC) curves and logistic regression analysis were used for statistical analysis.
RESULTS: The prevalence of a positive amniotic fluid culture was 7.2% (11/153) and the prevalence of intra-amniotic inflammation was 19.6% (30/153). The final logistic regression model was based on non-invasive clinical variables, including gestational age at assessment, cervical length and maternal blood WBC count, which were the best predictors of intra-amniotic inflammation. The model was shown to have an adequate goodness of fit (P = 0.754), and the area under the ROC curve was 0.724, indicating reasonably good discrimination.
CONCLUSION: In women with preterm labor and intact membranes, the risk for intra-amniotic inflammation can be predicted non-invasively with a risk score based on gestational age, cervical length and maternal blood WBC count.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21031346     DOI: 10.1002/uog.8869

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  6 in total

1.  Relation between amniotic fluid infection or cytokine levels and hearing screen failure in infants at 32 wk gestation or less.

Authors:  Eun Young Jung; Byung Yoon Choi; Jihye Rhee; Jaehong Park; Soo-Hyun Cho; Kyo Hoon Park
Journal:  Pediatr Res       Date:  2016-11-03       Impact factor: 3.756

2.  Frequency and clinical significance of short cervix in patients with preterm premature rupture of membranes.

Authors:  Seung Mi Lee; Kyo Hoon Park; Eun Young Jung; Ji Ae Jang; Ha-Na Yoo
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

3.  Amniotic Fluid Infection, Cytokine Levels, and Mortality and Adverse Pulmonary, Intestinal, and Neurologic Outcomes in Infants at 32 Weeks' Gestation or Less.

Authors:  Eun Young Jung; Kyo Hoon Park; Bo Ryoung Han; Soo Hyun Cho; Ha Na Yoo; Juyoung Lee
Journal:  J Korean Med Sci       Date:  2017-03       Impact factor: 2.153

4.  Vitamin D-binding protein in cervicovaginal fluid as a non-invasive predictor of intra-amniotic infection and impending preterm delivery in women with preterm labor or preterm premature rupture of membranes.

Authors:  Song Yi Kook; Kyo Hoon Park; Ji Ae Jang; Yu Mi Kim; Hyunsoo Park; Se Jeong Jeon
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

5.  A clinical prediction rule for histological chorioamnionitis in preterm newborns.

Authors:  Jasper V Been; Sizzle F Vanterpool; Jasmijn D E de Rooij; G Ingrid J G Rours; René F Kornelisse; Martien C J M van Dongen; Christel J A W van Gool; Ronald R de Krijger; Peter Andriessen; Luc J I Zimmermann; Boris W Kramer
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

6.  Prolidase, matrix metalloproteinases 1 and 13 activity, oxidative-antioxidative status as a marker of preterm premature rupture of membranes and chorioamnionitis in maternal vaginal washing fluids.

Authors:  Hatice Ender Soydinc; Muhammet Erdal Sak; Osman Evliyaoglu; Mehmet Sıddık Evsen; Abdulkadir Turgut; Ali Özler; İsmail Yıldız; Talip Gul
Journal:  Int J Med Sci       Date:  2013-08-15       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.